Literature DB >> 5064701

Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor (MIF).

N P Plotnikoff, A J Kastin, M S Anderson, A V Schally.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5064701     DOI： 10.3181/00379727-140-36558

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  10 in total

1.  On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use.

Authors:  S Björkman; H Sievertsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-06       Impact factor: 3.000

Review 2.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

3.  Effects of arecoline and cholinesterase inhibitors on cyclic guanosine 3',5'-monophosphate and adenosine 3'.5'-monophosphate in mouse brain.

Authors:  V Dinnendahl; K Stock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

4.  Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy.

Authors:  T Caraceni; E A Parati; F Girotti; I Celano; C Frigerio; D Cocchi; E E Müller
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

5.  Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

Authors:  A Barbeau; M Roy; A J Kastin
Journal:  Can Med Assoc J       Date:  1976-01-24       Impact factor: 8.262

6.  Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease.

Authors:  A J Kastin; A Barbeau
Journal:  Can Med Assoc J       Date:  1972-12-09       Impact factor: 8.262

7.  Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors:  J R Bianchine; L Sunyapridakul
Journal:  Drugs       Date:  1973       Impact factor: 9.546

8.  Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia.

Authors:  R Walter; P L Hoffman; J B Flexner; L B Flexner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

9.  Mass spectrometric quantification of MIF-1 in mouse brain by multiple reaction monitoring.

Authors:  Indu Kheterpal; Abba J Kastin; Sahana Mollah; Chuanhui Yu; Hung Hsuchou; Weihong Pan
Journal:  Peptides       Date:  2009-04-11       Impact factor: 3.750

10.  MSH-release inhibiting factors: recent studies.

Authors:  A J Kastin; N P Plotnikoff; S Viosca; M S Anderson; A V Schally
Journal:  Yale J Biol Med       Date:  1973-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.